Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pooja Desai

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
Advances in Therapy|May 4, 2023
Real-World Modifications of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Hyperkalemia Initiating Sodium Zirconium Cyclosilicate Therapy: The OPTIMIZE I StudyAbiy Agiro, Amin An, Erin E Cook, et al.
American Journal of Nephrology|September 23, 2020
Real World Use and Effects of Calcimimetics in Treating Mineral and Bone Disorder in Hemodialysis PatientsMark D Danese, Deborah Lubeck, Vasily Belozeroff, et al.
Neoplasia (New York, N.Y.)|June 28, 2014
PARPi-FL--a fluorescent PARP1 inhibitor for glioblastoma imagingChristopher P Irwin, Yasiri Portorreal, Christian Brand, et al.
Proceedings of the SIGCHI Conference on Human Factors in Computing Systems. CHI Conference|November 7, 2025
T2 Coach: A Qualitative Study of an Automated Health Coach for Diabetes Self-ManagementElliot G Mitchell, Pooja Desai, Arlene Smaldone, et al.
Kidney360|April 4, 2022
Calcimimetic Use in Dialysis-Dependent Medicare Fee-for-Service Beneficiaries and Implications for Bundled PaymentMark Gooding, Pooja Desai, Holly Owens, et al.
Journal of Managed Care & Specialty Pharmacy|October 31, 2017
Factors Associated with Direct Health Care Costs Among Patients with MigraineMachaon Bonafede, Qian Cai, Katherine Cappell, et al.
Bioconjugate Chemistry|February 23, 2018
Synthesis and Evaluation of a Novel <sup>64</sup>Cu- and <sup>67</sup>Ga-Labeled Neurokinin 1 Receptor Antagonist for in Vivo Targeting of NK1R-Positive Tumor XenograftsHanwen Zhang, Ananda Kumar Kanduluru, Pooja Desai, et al.
Journal of Managed Care & Specialty Pharmacy|August 5, 2024
Economic burden of recurrent hyperkalemia in patients with chronic kidney diseaseGeorge Bakris, Abiy Agiro, Alexandra Greatsinger, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 17, 2021
Etelcalcetide Utilization, Dosing Titration, and Chronic Kidney Disease-Mineral and Bone Disease (CKD-MBD) Marker Responses in US Hemodialysis PatientsAngelo Karaboyas, Daniel Muenz, Douglas S Fuller, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|March 14, 2020
Amiodarone: A Comprehensive Guide for CliniciansDavid Hamilton, Shuktika Nandkeolyar, Howard Lan, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Advances in Therapy|May 4, 2023
Real-World Modifications of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Hyperkalemia Initiating Sodium Zirconium Cyclosilicate Therapy: The OPTIMIZE I StudyAbiy Agiro, Amin An, Erin E Cook, et al.
American Journal of Nephrology|September 23, 2020
Real World Use and Effects of Calcimimetics in Treating Mineral and Bone Disorder in Hemodialysis PatientsMark D Danese, Deborah Lubeck, Vasily Belozeroff, et al.
Neoplasia (New York, N.Y.)|June 28, 2014
PARPi-FL--a fluorescent PARP1 inhibitor for glioblastoma imagingChristopher P Irwin, Yasiri Portorreal, Christian Brand, et al.
Proceedings of the SIGCHI Conference on Human Factors in Computing Systems. CHI Conference|November 7, 2025
T2 Coach: A Qualitative Study of an Automated Health Coach for Diabetes Self-ManagementElliot G Mitchell, Pooja Desai, Arlene Smaldone, et al.
Kidney360|April 4, 2022
Calcimimetic Use in Dialysis-Dependent Medicare Fee-for-Service Beneficiaries and Implications for Bundled PaymentMark Gooding, Pooja Desai, Holly Owens, et al.
Journal of Managed Care & Specialty Pharmacy|October 31, 2017
Factors Associated with Direct Health Care Costs Among Patients with MigraineMachaon Bonafede, Qian Cai, Katherine Cappell, et al.
Bioconjugate Chemistry|February 23, 2018
Synthesis and Evaluation of a Novel <sup>64</sup>Cu- and <sup>67</sup>Ga-Labeled Neurokinin 1 Receptor Antagonist for in Vivo Targeting of NK1R-Positive Tumor XenograftsHanwen Zhang, Ananda Kumar Kanduluru, Pooja Desai, et al.
Journal of Managed Care & Specialty Pharmacy|August 5, 2024
Economic burden of recurrent hyperkalemia in patients with chronic kidney diseaseGeorge Bakris, Abiy Agiro, Alexandra Greatsinger, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 17, 2021
Etelcalcetide Utilization, Dosing Titration, and Chronic Kidney Disease-Mineral and Bone Disease (CKD-MBD) Marker Responses in US Hemodialysis PatientsAngelo Karaboyas, Daniel Muenz, Douglas S Fuller, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|March 14, 2020
Amiodarone: A Comprehensive Guide for CliniciansDavid Hamilton, Shuktika Nandkeolyar, Howard Lan, et al.
Pageof 7